Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisanne Beugelink

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[Unexpected recurrence of malaria]Lisanne Beugelink, Karin B Gast, Jaco J Verweij, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 23, 2022
[Hypercalcemia after hyperkalemia]David M de Groot, Lisanne Beugelink, Ronald W van Etten
Scientific Reports|January 13, 2021
High-salt intake affects retinal vascular tortuosity in healthy males: an exploratory randomized cross-over trialEliane F E Wenstedt, Lisanne Beugelink, Esmee M Schrooten, et al.
Blood Advances|July 17, 2025
Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemiaEmma L Boertjes, Christian M Vonk, François G Kavelaars, et al.
Blood|June 4, 2026
ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid LeukemiaChristopher S Hourigan, Lisanne Beugelink, Jad Othman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[Unexpected recurrence of malaria]Lisanne Beugelink, Karin B Gast, Jaco J Verweij, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 23, 2022
[Hypercalcemia after hyperkalemia]David M de Groot, Lisanne Beugelink, Ronald W van Etten
Scientific Reports|January 13, 2021
High-salt intake affects retinal vascular tortuosity in healthy males: an exploratory randomized cross-over trialEliane F E Wenstedt, Lisanne Beugelink, Esmee M Schrooten, et al.
Blood Advances|July 17, 2025
Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemiaEmma L Boertjes, Christian M Vonk, François G Kavelaars, et al.
Blood|June 4, 2026
ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid LeukemiaChristopher S Hourigan, Lisanne Beugelink, Jad Othman, et al.
Pageof 1